Cochrane Systematic Review: Naloxone for shock
Boeuf B, Poirier V, Gauvin F, Guerguerian AM, Roy C, Farrell CA, Lacroix J
Boeuf B, Poirier V, Gauvin F, Guerguerian AM, Roy C, Farrell CA, Lacroix J
OBJECTIVES: To evaluate the effectiveness and safety of naloxone in human shock and to estimate the methodological quality of the clinical trials.
OBJECTIVES: To evaluate the effectiveness and safety of naloxone in human shock and to estimate the methodological quality of the clinical trials.
Cochrane Systematic Review: Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock
Sheikh A, Shehata YA, Brown SG, Simons FE
Sheikh A, Shehata YA, Brown SG, Simons FE
OBJECTIVES: To assess the benefits and harms of adrenaline (epinephrine) in the treatment of anaphylaxis.
OBJECTIVES: To assess the benefits and harms of adrenaline (epinephrine) in the treatment of anaphylaxis.
Cochrane Systematic Review: Naloxone for shock
Boeuf B, Poirier V, Gauvin F, Guerguerian AM, Roy C, Farrell CA, Lacroix J
Boeuf B, Poirier V, Gauvin F, Guerguerian AM, Roy C, Farrell CA, Lacroix J
OBJECTIVES: To evaluate the effectiveness and safety of naloxone in human shock and to estimate the methodological quality of the clinical trials.
OBJECTIVES: To evaluate the effectiveness and safety of naloxone in human shock and to estimate the methodological quality of the clinical trials.
Cochrane Systematic Review: Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock
Sheikh A, Shehata YA, Brown SG, Simons FE
Sheikh A, Shehata YA, Brown SG, Simons FE
OBJECTIVES: To assess the benefits and harms of adrenaline (epinephrine) in the treatment of anaphylaxis.
OBJECTIVES: To assess the benefits and harms of adrenaline (epinephrine) in the treatment of anaphylaxis.